Literature DB >> 24396068

IκB kinase ε targets interferon regulatory factor 1 in activated T lymphocytes.

Marco Sgarbanti1, Giulia Marsili, Anna Lisa Remoli, Emilia Stellacci, Antonello Mai, Dante Rotili, Edvige Perrotti, Chiara Acchioni, Roberto Orsatti, Nunzio Iraci, Mathieu Ferrari, Alessandra Borsetti, John Hiscott, Angela Battistini.   

Abstract

IκB kinase ε (IKK-ε) has an essential role as a regulator of innate immunity, functioning downstream of pattern recognition receptors to modulate NF-κB and interferon (IFN) signaling. In the present study, we investigated IKK-ε activation following T cell receptor (TCR)/CD28 stimulation of primary CD4(+) T cells and its role in the stimulation of a type I IFN response. IKK-ε was activated following TCR/CD28 stimulation of primary CD4(+) T cells; however, in T cells treated with poly(I·C), TCR/CD28 costimulation blocked induction of IFN-β transcription. We demonstrated that IKK-ε phosphorylated the transcription factor IFN regulatory factor 1 (IRF-1) at amino acid (aa) 215/219/221 in primary CD4(+) T cells and blocked its transcriptional activity. At the mechanistic level, IRF-1 phosphorylation impaired the physical interaction between IRF-1 and the NF-κB RelA subunit and interfered with PCAF-mediated acetylation of NF-κB RelA. These results demonstrate that TCR/CD28 stimulation of primary T cells stimulates IKK-ε activation, which in turn contributes to suppression of IFN-β production.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24396068      PMCID: PMC3958032          DOI: 10.1128/MCB.01161-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter.

Authors:  T Agalioti; S Lomvardas; B Parekh; J Yie; T Maniatis; D Thanos
Journal:  Cell       Date:  2000-11-10       Impact factor: 41.582

2.  Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program.

Authors:  Hideo Negishi; Yasuyuki Fujita; Hideyuki Yanai; Shinya Sakaguchi; Xinshou Ouyang; Masahiro Shinohara; Hiroshi Takayanagi; Yusuke Ohba; Tadatsugu Taniguchi; Kenya Honda
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-03       Impact factor: 11.205

Review 3.  The IRF family transcription factors in immunity and oncogenesis.

Authors:  Tomohiko Tamura; Hideyuki Yanai; David Savitsky; Tadatsugu Taniguchi
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

4.  Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA.

Authors:  Bo Huang; Xiao-Dong Yang; Ming-Ming Zhou; Keiko Ozato; Lin-Feng Chen
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

5.  Identification of 4-hydroxyquinolines inhibitors of p300/CBP histone acetyltransferases.

Authors:  Antonello Mai; Dante Rotili; Domenico Tarantino; Angela Nebbioso; Sabrina Castellano; Gianluca Sbardella; Marc Tini; Lucia Altucci
Journal:  Bioorg Med Chem Lett       Date:  2008-12-30       Impact factor: 2.823

6.  Viral activation of interleukin-15 (IL-15): characterization of a virus-inducible element in the IL-15 promoter region.

Authors:  N Azimi; K M Shiramizu; Y Tagaya; J Mariner; T A Waldmann
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

7.  NF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylation.

Authors:  F Nomura; T Kawai; K Nakanishi; S Akira
Journal:  Genes Cells       Date:  2000-03       Impact factor: 1.891

8.  IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer.

Authors:  Marco Sgarbanti; Anna L Remoli; Giulia Marsili; Barbara Ridolfi; Alessandra Borsetti; Edvige Perrotti; Roberto Orsatti; Ramona Ilari; Leonardo Sernicola; Emilia Stellacci; Barbara Ensoli; Angela Battistini
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

9.  Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation.

Authors:  Jessica E Hutti; Rhine R Shen; Derek W Abbott; Alicia Y Zhou; Kam M Sprott; John M Asara; William C Hahn; Lewis C Cantley
Journal:  Mol Cell       Date:  2009-05-14       Impact factor: 17.970

10.  Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation.

Authors:  Kristopher Clark; Lorna Plater; Mark Peggie; Philip Cohen
Journal:  J Biol Chem       Date:  2009-03-22       Impact factor: 5.157

View more
  14 in total

Review 1.  Type I interferon signaling, regulation and gene stimulation in chronic virus infection.

Authors:  Sabelo Lukhele; Giselle M Boukhaled; David G Brooks
Journal:  Semin Immunol       Date:  2019-05-30       Impact factor: 11.130

2.  Lupus-associated endogenous retroviral LTR polymorphism and epigenetic imprinting promote HRES-1/RAB4 expression and mTOR activation.

Authors:  Aparna Godavarthy; Ryan Kelly; John Jimah; Miguel Beckford; Tiffany Caza; David Fernandez; Nick Huang; Manuel Duarte; Joshua Lewis; Hind J Fadel; Eric M Poeschla; Katalin Banki; Andras Perl
Journal:  JCI Insight       Date:  2020-01-16

3.  Therapeutic activity of multiple common γ-chain cytokine inhibition in acute and chronic GVHD.

Authors:  Anne-Kathrin Hechinger; Benjamin A H Smith; Ryan Flynn; Kathrin Hanke; Cameron McDonald-Hyman; Patricia A Taylor; Dietmar Pfeifer; Björn Hackanson; Franziska Leonhardt; Gabriele Prinz; Heide Dierbach; Annette Schmitt-Graeff; Jiri Kovarik; Bruce R Blazar; Robert Zeiser
Journal:  Blood       Date:  2014-10-28       Impact factor: 22.113

4.  Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus.

Authors:  Chiara Acchioni; Anna Lisa Remoli; Giulia Marsili; Marta Acchioni; Ilenia Nardolillo; Roberto Orsatti; Stefania Farcomeni; Enrico Palermo; Edvige Perrotti; Maria Letizia Barreca; Stefano Sabatini; Silvia Sandini; Cristina Parolin; Rongtuan Lin; Alessandra Borsetti; John Hiscott; Marco Sgarbanti
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

Review 5.  TCR signaling to NF-κB and mTORC1: Expanding roles of the CARMA1 complex.

Authors:  Jian-hong Shi; Shao-Cong Sun
Journal:  Mol Immunol       Date:  2015-08-08       Impact factor: 4.407

Review 6.  HIV-1 latency: an update of molecular mechanisms and therapeutic strategies.

Authors:  Angela Battistini; Marco Sgarbanti
Journal:  Viruses       Date:  2014-04-14       Impact factor: 5.048

7.  5-Azacytidine modulates interferon regulatory factor 1 in macrophages to exert a cardioprotective effect.

Authors:  Hye-Yun Jeong; Wan Seok Kang; Moon Hwa Hong; Hae Chang Jeong; Myun-Geun Shin; Myung Ho Jeong; Yong Sook Kim; Youngkeun Ahn
Journal:  Sci Rep       Date:  2015-10-29       Impact factor: 4.379

8.  HIV-1 Tat Recruits HDM2 E3 Ligase To Target IRF-1 for Ubiquitination and Proteasomal Degradation.

Authors:  Anna Lisa Remoli; Giulia Marsili; Edvige Perrotti; Chiara Acchioni; Marco Sgarbanti; Alessandra Borsetti; John Hiscott; Angela Battistini
Journal:  mBio       Date:  2016-10-18       Impact factor: 7.867

9.  GSK3β-SCFFBXW7α mediated phosphorylation and ubiquitination of IRF1 are required for its transcription-dependent turnover.

Authors:  Alexander J Garvin; Ahmed H A Khalaf; Alessandro Rettino; Jerome Xicluna; Laura Butler; Joanna R Morris; David M Heery; Nicole M Clarke
Journal:  Nucleic Acids Res       Date:  2019-05-21       Impact factor: 16.971

10.  MEK1/2 Inhibitors Unlock the Constrained Interferon Response in Macrophages Through IRF1 Signaling.

Authors:  Lei Yang; Jeak Ling Ding
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.